Unveiling the anti-inflammatory potential of 11β,13-dihydrolactucin for application in inflammatory bowel disease management-Reference-Cited by-同舟云学术

Unveiling the anti-inflammatory potential of 11β,13-dihydrolactucin for application in inflammatory bowel disease management

Published:2024 Issue: Volume: Page:
ISSN:2042-6496
Container-title:Food & Function
language:en
Short-container-title:Food Funct.

Author:

Matos Melanie S.¹²^ORCID,Ávila-Gálvez María Ángeles¹³,González-Sarrías Antonio⁴^ORCID,Silva Nuno-Valério³,Crespo Carolina Lage³^ORCID,Jacinto António³⁵^ORCID,Serra Ana Teresa¹²,Matias Ana A.¹,Nunes dos Santos Cláudia¹²³⁵^ORCID

Affiliation:

1. Instituto de Biologia Experimental e Tecnológica (iBET), 2780-157 Oeiras, Portugal

2. Instituto de Tecnologia Química e Biológica António Xavier, Universidade Nova de Lisboa (ITQB-NOVA), 2780-157 Oeiras, Portugal

3. NOVA Medical School, Faculdade de Ciências Médicas, NMS|FCM, Universidade Nova de Lisboa, 1169-056 Lisboa, Portugal

4. Laboratory of Food & Health, Research Group on Quality, Safety and Bioactivity of Plant Foods, CEBAS-CSIC, 30100 Campus de Espinardo, Murcia, Spain

5. NOVA Institute for Medical Systems Biology, NIMSB, Universidade Nova de Lisboa, 1099-085 Lisboa, Portugal

Abstract

11β,13-Dihydrolactucin, a sesquiterpene lactone found in chicory, presents promising anti-inflammatory potential in complementary in vitro and in vivo models of intestinal inflammation, acting at several levels of the cellular inflammatory response.

Funder

Horizon 2020 Framework Programme

Fundação para a Ciência e a Tecnologia

European Commission

Publisher

Royal Society of Chemistry (RSC)

Link

http://pubs.rsc.org/en/content/articlepdf/2024/FO/D4FO01446D

Reference64 articles.

1. Origin and physiological roles of inflammation

2. High frequency of early colorectal cancer in inflammatory bowel disease

3. Global burden of inflammatory bowel disease 1990-2019: A systematic examination of the disease burden and twenty-year forecast

4. Secondary causes of inflammatory bowel diseases

5. Sex-Based Differences in Incidence of Inflammatory Bowel Diseases—Pooled Analysis of Population-Based Studies From Western Countries